XML 68 R54.htm IDEA: XBRL DOCUMENT v3.7.0.1
Acquisition of Senhance Surgical Robotic System - Additional Information (Detail)
3 Months Ended 12 Months Ended
Dec. 30, 2016
EUR (€)
shares
Sep. 21, 2016
Sep. 21, 2015
USD ($)
shares
Dec. 31, 2015
USD ($)
Sep. 30, 2015
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2016
EUR (€)
Dec. 31, 2015
USD ($)
Dec. 30, 2016
USD ($)
Dec. 30, 2016
EUR (€)
Sep. 21, 2015
EUR (€)
Business Acquisition [Line Items]                      
Securities consideration held in escrow percentage     10.00%                
Escrow and security interest period     24 months                
Intellectual property, net       $ 46,898,000   $ 37,090,000   $ 46,898,000      
Legal, consulting and other costs related to acquisition       $ 228,000 $ 4,003,000 $ 0   4,231,000      
Minimum [Member]                      
Business Acquisition [Line Items]                      
Amortization period           7 years 7 years        
Senhance Surgical Robotic System Acquisition [Member]                      
Business Acquisition [Line Items]                      
Common shares issued | shares     15,543,413                
Cash consideration     $ 25,000,000                
Percentage of securities consideration released from lock out restrictions   50.00%                  
Percentage of securities consideration   50.00%                  
Acquisition agreement, description           The Lock-up Agreement provides that an additional twenty-five percent of the Securities Consideration remains locked-up until the eighteen-month anniversary of the Closing Date, and the remaining twenty-five percent of the Securities Consideration remains locked-up until the two-year anniversary of the Closing Date. The Lock-up Agreement provides that an additional twenty-five percent of the Securities Consideration remains locked-up until the eighteen-month anniversary of the Closing Date, and the remaining twenty-five percent of the Securities Consideration remains locked-up until the two-year anniversary of the Closing Date.        
Intellectual property, net     $ 48,500,000                
Amortization period     7 years                
Senhance Surgical Robotic System Acquisition [Member] | Ending on Eighteen Month Anniversary [Member]                      
Business Acquisition [Line Items]                      
Percentage of securities consideration   25.00%                  
Senhance Surgical Robotic System Acquisition [Member] | Ending on Two Year Anniversary [Member]                      
Business Acquisition [Line Items]                      
Percentage of securities consideration   25.00%                  
Senhance Surgical Robotic System Acquisition [Member] | First Tranche [Member]                      
Business Acquisition [Line Items]                      
Cash consideration     $ 25,000,000                
Senhance Surgical Robotic System Acquisition [Member] | Second Tranche [Member]                      
Business Acquisition [Line Items]                      
Common shares issued | shares 3,722,685                    
Cash consideration payable | €                   € 10,000,000  
Aggregate fair market value | € € 5,000,000                    
Aggregate fair market value payment | €                   € 5,000,000  
Gross proceeds from financing                 $ 50,000,000    
Interest rate                 9.00% 9.00%  
Senhance Surgical Robotic System Acquisition [Member] | Second Tranche [Member] | Lincoln Park Capital Fund, LLC [Member]                      
Business Acquisition [Line Items]                      
Gross proceeds from financing           $ 50,000,000          
Interest rate           9.00%          
Senhance Surgical Robotic System Acquisition [Member] | Second Tranche [Member] | Minimum [Member]                      
Business Acquisition [Line Items]                      
Cash on hand                 $ 50,000,000    
Senhance Surgical Robotic System Acquisition [Member] | Second Tranche [Member] | Minimum [Member] | Lincoln Park Capital Fund, LLC [Member]                      
Business Acquisition [Line Items]                      
Cash on hand           $ 50,000,000          
Senhance Surgical Robotic System Acquisition [Member] | Third Tranche [Member]                      
Business Acquisition [Line Items]                      
Cash consideration payable | €                     € 15,000,000
Senhance Surgical Robotic System Acquisition [Member] | Third Tranche [Member] | Minimum [Member]                      
Business Acquisition [Line Items]                      
Target revenue to be achieved | €                     25,000,000
Senhance Surgical Robotic System Acquisition [Member] | Fourth Tranche [Member]                      
Business Acquisition [Line Items]                      
Cash consideration | €             € 1,100,000        
Cash consideration payable | €                     2,500,000
Senhance Surgical Robotic System Acquisition [Member] | U.S. Dollars [Member]                      
Business Acquisition [Line Items]                      
Cash consideration     $ 25,000,000                
Senhance Surgical Robotic System Acquisition [Member] | Euro [Member]                      
Business Acquisition [Line Items]                      
Cash consideration payable | €                     € 27,500,000
TransEnterix Italia [Member]                      
Business Acquisition [Line Items]                      
Membership interests percentage under Security agreement     10.00%               10.00%
Legal, consulting and other costs related to acquisition               $ 4,200,000